Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary Syndrome

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 17095 participants.

Also called NCT05183178

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 17,095 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05183178
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Sweden (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05183178. Randomized; no masking; primary purpose treatment. Start 2022-02-01 (actual); primary completion 2025-08-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary Syndrome
Acronym
SWITCH
Condition
Acute Coronary Syndrome
Intervention (Drug)
Prasugrel 10 mg p.o
Intervention (Drug)
Ticagrelor 90 mg
Lead sponsor
Vastra Gotaland Region (class: other government)
Collaborator
Region Skane (class: other)
Collaborator
Region Halland (class: other)
Collaborator
Region Gävleborg (class: other)
Collaborator
Region Örebro County (class: other)
Collaborator
Region Västerbotten (class: other government)
Collaborator
Jämtland County Council, Sweden (class: other government)

Record details

Record id
cardio:ct-nct05183178
Content hash
b5d8babc1f7528cac4ff7307d4846446adfa2a7f7df150fb44de8fc68ffd9ad3